Nagement of high-risk or low-value medicines. The membership contains representation from disciplines and specialities from across the hospital and is chaired by the Director of Internal Medicine and Aged Care.Pharmacy 2021, 9,Pharmacy 2021, 9, x FOR PEER REVIEW4 of4 ofFigure 1. The role in the MUP pharmacist. Figure 1. The function with the MUP pharmacist.two.three. Governance Structure two.4. Price Containment activities The activities from the MUP pharmacist are governed by the Quality Use of Medicines A record of all expense containment activities was kept. Expense savings were calculated (QUM) Subcommittee which in turn reports towards the Hospital Medicines Advisory Commitdepending on activity. Savings generated by adjustments to preferential contracts, improvetee. The overall purpose on the QUM Subcommittee should be to coordinate the organisational ment in stock management, and right reimsbursment, for instance, have been made on response for the management of QUM in accordance with very best practice. By way of its ac12-month usage. tivities, this Subcommittee aims to ensure the implementation, sustainability and ongoing improvement of practices associated with medicines across the hospital. One of several main re2.five. Dissemination of Study findings sponsibilities of your committee will be to guide the implementation of strategies to improve Dissemination of Medication Utilisation Plan unique, this and activities had been QUM within the organisation to reduce patient danger. In study findings involves help reported and produced available to all relevant stakeholders, includingor low-value medicastrategies which enhance governance and management of high-risk the Director of Clinical Pharmacology, Director of Pharmacy, the High-Cost Drugs Committee,specialities from tions. The membership involves representation from disciplines and along with the Medicines Advisory Committee. is chairedundertaking these activities are encouragedCare. across the hospital and All staff by the Director of Internal Medicine and Aged to submit manuscripts for publication to peer reviewed journals and submit abstracts for conference presentation. 2.four. Cost Containment Activities A record of all price containment activities was kept. Price savings had been calculated three. Results depending on activity. Savings generated by changes to preferential contracts, improve3.1. Strategic Planning ment in stock management, and right reimsbursment, by way of example, have been produced on 12-The Medication Utilisation System strategic program (Table 1) was developed to align month usage. with the hospital’s strategic plan for 2020024 that includes objectives, techniques and two.five. Dissemination of Study Findings important functionality indicators (KPIs). KPIs were developed applying several principles, such as making certain that they have been simple to measure, Cefalonium Purity & Documentation feasible and clearly findings and activities have been Dissemination of Medication Utilisation System study reflecting progress and performance. Intelligent (distinct, measurable, achievable, realistic and time bound) objectives were reported and produced available to all relevant stakeholders, which includes the Director of Clinical made use of within the improvement.of Pharmacy, reviewed after Drugs months postand the MediPharmacology, Director KPIs will be the High-Cost 184 Committee, implementation in the role. cines Advisory Committee. All employees undertaking these activities are encouraged to submit manuscripts for publication to peer reviewed journals and submit abstracts for conference presentation.3. Outcomes three.1. Strategic PlanningPharmacy 20.
